0001932193-22-000001.txt : 20220623 0001932193-22-000001.hdr.sgml : 20220623 20220621141854 ACCESSION NUMBER: 0001932193-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 EFFECTIVENESS DATE: 20220621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RS BioTherapeutics Inc. CENTRAL INDEX KEY: 0001932193 IRS NUMBER: 880778666 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-449739 FILM NUMBER: 221027541 BUSINESS ADDRESS: STREET 1: 157 BALTIMORE STREET CITY: CUMBERLAND STATE: MD ZIP: 21502 BUSINESS PHONE: 717.433.5390 MAIL ADDRESS: STREET 1: 157 BALTIMORE STREET CITY: CUMBERLAND STATE: MD ZIP: 21502 D 1 primary_doc.xml X0708 D LIVE 0001932193 RS BioTherapeutics Inc. 157 BALTIMORE STREET CUMBERLAND MD MARYLAND 21502 717.433.5390 DELAWARE Real Science, Inc. None Corporation true 2021 H. Dean Hart 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Justin Molignoni 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Director Dustin Freas 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Director Michael Guzman 157 Baltimore Street Cumberland MD MARYLAND 21502 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-06-09 false true false 50000 4000000 685021 3314979 false 6 0 0 886667 true false RS BioTherapeutics Inc. /s/ Justin Molignoni Justin Molignoni Chairman of the Board 2022-06-21